viral
pandem
remain
seriou
threat
humankind
everi
year
known
virus
hepat
b
viru
newli
infect
million
peopl
across
globe
addit
recent
outbreak
ebola
viru
influenza
viru
sever
acut
respiratori
syndrom
sar
coronaviru
middl
east
respiratori
syndromecoronaviru
merscov
serv
remind
silent
danger
world
health
organ
report
million
causal
per
year
connect
hepat
b
almost
hepat
c
occasion
epidem
outbreak
virus
also
strike
includ
outbreak
norovirus
flavivirus
zika
dengu
virus
new
strain
influenza
virus
reemerg
west
nile
viru
itali
unit
state
despit
rel
long
paus
virus
influenza
viru
reemerg
caus
global
pandem
health
problem
unlik
cellular
genom
consist
doublestrand
ds
dna
viral
genom
form
broad
varieti
nucleic
acid
na
includ
ds
singlestrand
ss
circular
linear
dna
posit
negativeor
sometim
ambisens
rna
viral
life
cycl
depend
cellular
factor
cellular
metabol
signal
pathway
number
possibl
antivir
drug
target
limit
howev
almost
virus
encod
uniqu
protein
enzym
may
serv
specif
target
antivir
therapi
overarch
goal
modern
drug
develop
effort
design
compound
specif
inhibit
viral
target
cellular
target
essenti
viru
replic
purpos
review
provid
insight
broad
varieti
cellbas
biochem
assay
use
identif
evalu
antivirot
includ
highthroughput
screen
ht
method
overview
avail
inhibitor
vaccin
review
elsewher
eg
de
clercq
li
beyond
scope
paper
packag
genom
particl
limit
size
virus
encod
gene
virion
consist
rna
dna
genom
protect
outer
shell
call
capsid
also
nucleocapsid
form
lattic
capsid
protein
envelop
virus
capsid
addit
surround
lipid
bilay
spike
viral
protein
size
anim
virus
rang
approxim
nm
nm
cohen
et
al
capsid
virion
rna
virus
adopt
variou
shape
viral
capsid
may
icosahedr
eg
picornavirida
astrovirida
reovirida
togavirida
bulletshap
rhabdovirida
helic
coronavirida
helic
filament
filovirida
orthomyxovirida
paramyxovirida
filament
arenavirida
bunyavirida
retrovir
capsid
core
may
conic
spheric
rodshap
morpholog
dna
virus
similarli
divers
rang
icosahedr
envelop
hepadnavirida
herpesvrida
nonenvelop
adenovirida
parvovirda
polyomavirida
papillomavirida
rodshap
baculovirida
pleomorph
poxvirida
viral
life
cycl
process
viral
replic
host
cell
first
virus
enter
host
cell
replic
genom
follow
translat
viral
protein
host
cell
machineri
virus
packag
genom
materi
protect
proteinac
capsid
exit
cell
infect
anoth
host
cell
nonenvelop
virus
consist
protein
capsid
shell
enclos
viral
genom
enzym
capsid
shell
envelop
virus
enclos
lipid
envelop
deriv
host
cell
membran
regardless
whether
viru
envelop
surfac
must
display
glyco
protein
suitabl
specif
interact
host
cell
receptor
contrast
surfac
protein
nonenvelop
virus
envelop
virus
usual
serv
anoth
function
addit
host
cell
recognit
attach
exampl
may
enabl
fusion
viral
cellular
membran
usual
interact
secondari
receptor
coreceptor
fusion
domain
viral
surfac
glycoprotein
thu
lower
kinet
barrier
energet
demand
membran
fusion
viral
particl
must
suffici
stabl
protect
genom
deliveri
host
cell
simultan
must
metast
allow
disassembl
releas
genom
replic
infect
cell
appropri
time
energet
barrier
prevent
viral
disassembl
outsid
cell
lower
upon
infect
structur
chang
viral
compon
chang
may
induc
bind
cellular
ligand
chang
environ
ph
chang
upon
enter
specif
cellular
compart
numer
virus
preassembl
immatur
particl
undergo
irrevers
usual
proteolyt
transit
matur
structur
fulli
infecti
virion
mutual
interact
viral
capsid
protein
typic
differ
cellular
protein
predominantli
creat
binari
interact
viral
structur
protein
interact
multipl
neighbor
partner
form
multicompon
macromolecular
structur
review
cheng
brook
jayaraman
et
al
economi
packag
viral
genom
due
limit
capsid
size
impli
format
type
structur
protein
usual
symmetr
organ
review
prasad
schmid
raguram
et
al
initi
stage
infect
virus
must
overcom
sever
obstacl
first
cellular
plasma
membran
actin
cortex
must
traffic
dens
cytoplasm
reach
final
destin
replic
assembl
pathway
specif
differ
virus
often
dictat
size
particl
structur
viral
life
cycl
divid
sever
common
stage
includ
entri
uncoat
genom
replic
genom
packag
assembl
releas
matur
fig
gener
first
phase
viral
infect
specif
recognit
target
host
cell
bind
surfac
receptor
display
cell
membran
process
common
envelop
nonenvelop
virus
envelop
virus
bind
mediat
viral
surfac
compon
typic
oligom
integr
glycoprotein
nonenvelop
virus
bind
receptor
site
project
capsid
surfac
virus
use
either
singl
receptor
eg
hepat
viru
polioviru
lowdens
lipoprotein
receptor
human
rhinoviru
multipl
receptor
equival
role
eg
hvem
herp
simplex
viru
ace
lsign
sar
coronaviru
virus
eg
hiv
hcv
adenovirus
rotavirus
picornavirus
herpesvirus
presenc
least
two
cytoplasm
membran
compon
requir
exampl
bind
primari
receptor
one
two
coreceptor
review
cossart
heleniu
grove
marsh
infect
cell
virus
must
overcom
plasma
membran
deliv
genet
materi
cytosol
virus
enter
cell
two
main
mechan
major
anim
virus
envelop
nonenvelop
enter
cell
one
two
type
endocytosi
clathrinmedi
endocytosi
eg
vsv
influenza
viru
rhinoviru
caveolinmedi
uptak
echoviru
polyoma
viru
clathrincaveolinindepend
endocytosi
caveolar
lipid
raftmedi
eg
polyomaviru
mous
macropinocytosi
eg
vaccinia
viru
respiratori
syncyti
viru
ebola
viru
blaa
cossart
heleniu
field
knipe
kirkham
parton
marech
et
al
mayor
pagano
mercer
heleniu
parton
simon
rasmussen
vilhardt
saeed
et
al
endocyt
mechan
enabl
viru
transport
cell
machineri
plasma
membran
pass
dens
actin
cortex
cellular
entri
virus
coupl
receptormedi
signal
result
activ
molecul
facilit
viru
entri
cytoskeleton
reorgan
induct
longdist
transport
viruscontain
vesicl
actin
cortex
disassembl
second
type
entri
use
envelop
virus
paramyxo
herp
retrovirus
upon
cell
surfac
receptor
bind
infect
cell
direct
fusion
viral
plasma
membran
neutral
ph
upon
intern
virus
becom
trap
enclos
vesicl
pinch
inner
side
plasma
membran
transport
cargo
cytoplasm
way
cell
transport
vesicl
undergo
matur
fuse
vesicl
fulfil
task
genom
replic
virus
escap
endosom
great
escap
trigger
activ
fusion
penetr
mechan
chang
condit
endosom
interior
eg
ph
ionic
environ
eg
calcium
ion
concentr
oxidoreduc
condit
chang
membran
composit
physicochem
cue
blaa
cossart
heleniu
inou
tsai
depend
requir
particular
viru
event
occur
earli
endosom
ph
eg
hepat
c
viru
vesicular
stomat
viru
late
endosom
ph
eg
influenza
viru
dengu
viru
sar
coronaviru
recycl
endosom
macropinosom
endoplasm
reticulum
golgi
apparatu
lysosom
ph
blaa
cossart
heleniu
grove
marsh
inou
tsai
major
anim
virus
activ
fusion
penetr
mechan
occur
conform
chang
structur
rearrang
viral
surfac
protein
andor
whole
virion
shell
may
destabil
capsid
core
structur
rearrang
envelop
virus
usual
mediat
fusion
viral
endosom
membran
nonenvelop
virus
structur
chang
uncov
amphipath
hydrophob
domain
may
induc
pore
format
disrupt
endosom
membran
deliv
genet
materi
replic
site
mechan
ultim
releas
viral
capsid
structur
endosom
vesicl
cytosol
either
fuse
endosom
membran
envelop
virus
penetr
endosom
membran
nonenvelop
virus
uncoat
partial
complet
disassembl
protect
capsid
shell
andor
lipid
envelop
liber
viral
genom
mani
virus
process
close
connect
conform
chang
induc
viru
bind
cell
surfac
receptor
low
ph
environ
chang
oxidoreduc
condit
ion
concentr
factor
envelop
virus
uncoat
involv
loss
viral
membran
fusion
either
plasma
membran
intracellular
vesicl
follow
stepwis
uncoat
protect
capsid
shell
nonenvelop
virus
uncoat
process
typic
involv
conform
chang
result
weaken
intermolecular
interact
loss
structur
protein
proteolyt
cleavag
field
knipe
depend
viru
uncoat
take
place
plasma
membran
cytoplasm
endocytosi
earli
late
endosom
lysosom
nucleu
nuclear
pore
complex
npc
ssrna
genom
retrovirus
fulli
enclos
insid
protect
capsid
shell
must
revers
transcrib
dsdna
releas
capsid
although
accept
uncoat
link
revers
transcript
nuclear
import
ambros
aiken
control
host
factor
eg
cyclophilin
precis
molecular
mechan
trigger
uncoat
remain
unknown
sever
hypothes
propos
includ
breakag
capsid
shell
due
increas
inner
pressur
caus
accumul
revers
transcript
product
rankov
et
al
requir
intact
microtubul
dynein
kinesin
motor
lukic
et
al
phosphoryl
capsid
shell
protein
host
cell
kinas
melk
takeuchi
et
al
contrast
major
rna
virus
replic
cytoplasm
dna
virus
except
larg
dna
virus
includ
poxvirida
asfarvirida
mimivirida
sever
neg
strand
rna
virus
enter
nucleu
replic
genom
kobil
et
al
koonin
yutin
passiv
diffus
nucleu
suitabl
molecul
smaller
nm
diamet
larger
structur
must
enter
nuclear
pore
complex
npc
accommod
molecul
nm
pant
kann
transloc
npc
tightli
regul
requir
presenc
nuclear
local
signal
nl
pass
molecul
nuclear
import
receptor
importin
karyopherin
cautain
et
al
due
divers
viral
particl
size
nm
nm
structur
virus
evolv
sever
strategi
export
dna
rna
genom
nucleoplasm
regard
npc
pathway
divid
npcdepend
npcindepend
mechan
due
size
limit
small
simplifi
scheme
common
stage
viral
life
cycl
target
antivir
drug
stage
includ
attach
entri
uncoat
genom
replic
genom
packag
assembl
viral
particl
viru
releas
matur
ruml
biotechnolog
advanc
viral
capsid
particl
hepat
b
viru
hbv
nm
diamet
pass
npc
cohen
et
al
rabe
et
al
importindepend
manner
hbv
disassembl
nuclear
side
npc
nuclear
basket
releas
genom
nucleoplasm
fay
capsid
shell
ribonucleoprotein
complex
rnp
larger
virus
influenza
viru
disassembl
within
cytoplasm
viral
genom
releas
shell
complex
nlscontain
compon
transloc
npc
ambros
aiken
campbel
hope
cohen
et
al
fay
hutchinson
fodor
anoth
mechan
use
herp
simplex
viru
hsv
adenovirus
involv
cellular
importin
nup
viral
proteinmedi
attach
dock
capsid
shell
cytoplasm
side
npc
facilit
passag
genom
dna
npc
either
eject
almost
intact
particl
capsid
portal
upon
complet
disassembl
capsid
shell
adenovirus
kremer
nemerow
ojala
et
al
pasdeloup
et
al
npcindepend
mechan
use
retrovirus
eg
mlv
enter
nucleu
mitot
phase
cell
divis
cycl
nuclear
envelop
dissolv
matreyek
engelman
roe
et
al
anoth
mechan
describ
parvovirus
involv
partial
disrupt
nuclear
envelop
cohen
pant
fay
viral
genom
encod
variou
type
na
summar
tabl
dna
virus
tabl
rna
virus
convent
ssdna
equival
polar
mrna
design
posit
strand
complementari
ssna
minu
polar
major
dna
virus
replic
nucleu
cellular
dna
replic
transcript
also
occur
contrast
rna
virus
usual
replic
cytoplasm
rna
virus
organ
store
genet
inform
form
rna
replic
genom
accomplish
either
rnadepend
rna
synthesi
fig
b
review
ferron
et
al
lu
gong
andino
et
al
tao
ye
rnadepend
dna
synthesi
revers
transcript
follow
dna
integr
replic
transcript
fig
enzymat
activ
commonli
found
uninfect
host
cell
rna
virus
must
encod
enzym
aid
replic
tabl
rna
virus
divid
accord
baltimor
classif
dsrna
virus
birnaand
reovirida
positivesens
ssrna
virus
corona
flavi
picornaviriad
negativesens
ssrna
virus
filo
rhabdo
paramyxo
orthomyxoviriad
ambisens
rna
virus
arenaand
member
bunyavirida
positiveand
negativesens
rna
nguyen
haenni
see
tabl
natur
genom
dictat
mechan
replic
also
import
consequ
genom
rna
virus
may
serv
directli
mrna
product
viral
protein
therefor
mere
introduct
genet
materi
eg
exocyt
vesicl
may
result
product
infect
rna
polymeras
copi
genet
materi
rna
virus
errorpron
provid
consider
genet
flexibl
propens
evolv
drugresist
mutant
featur
amplifi
virus
segment
genom
undergo
reassort
virus
segment
genom
orthomyxovirida
arenavirida
bunyavirida
segment
transcrib
autonom
transcriptionrepl
unit
viral
rna
polymeras
bind
end
cap
structur
note
genom
rna
grna
cap
uniqu
mechan
call
capsnatch
ferron
et
al
cap
cleav
cellular
mrna
transfer
onto
viral
grna
subunit
viral
rna
polymeras
pflug
et
al
dsrna
virus
birnavirida
reovirida
also
contain
segment
genom
upon
replic
virus
must
ensur
stoichiometr
incorpor
singl
copi
grna
segment
new
particl
guid
specif
packag
signal
segment
grna
interact
posit
charg
domain
capsid
protein
review
isel
et
al
pohl
et
al
although
differ
model
packag
propos
variou
segment
genom
virus
common
featur
coassembl
capsid
protein
grna
rna
polymeras
genom
dna
virus
come
consider
varieti
size
shape
small
ss
larg
ds
molecul
may
linear
circular
size
rang
genom
kb
kb
reflect
necess
virus
encod
specif
protein
requir
viral
replic
smallgenom
dna
virus
polyoma
papilloma
parvovirus
use
host
cell
enzym
replic
transcript
except
hepadnavirus
eg
hepat
b
viru
despit
small
genom
approxim
kb
encod
specif
dna
polymeraserevers
transcriptas
revers
transcrib
pregenom
rna
pgrna
genom
viral
dna
fig
ii
beck
nassal
virus
intermediates
genom
kb
eg
adenovirus
encod
dna
polymeras
genom
replic
usual
util
cellular
rna
polymeras
ii
iii
transcript
field
knipe
virus
larg
genom
larger
kb
eg
herpesvirus
encod
protein
replic
includ
dna
polymeras
dna
helicaseprimas
well
enzym
necessari
biosynthesi
deoxyribonucleotid
triphosph
dntp
sever
transcript
factor
boehmer
nimonkar
poxvirus
eg
vaccinia
viru
anoth
type
viru
larg
dsdna
genom
replic
transcript
translat
take
place
entir
cytoplasm
within
discret
juxtanuclear
site
call
viru
factori
moss
fig
iii
virus
encod
enzym
specif
factor
necessari
genom
replic
transcript
replic
machineri
largegenom
dna
virus
replic
nondivid
cell
contrast
replic
smallgenom
dna
virus
depend
cellular
dna
polymeras
must
occur
simultan
sphase
cell
cycl
eg
parvovirus
must
express
viral
protein
oncogen
reprogram
host
cellcycl
regulatori
protein
retinoblastoma
protein
prb
trigger
entri
sphase
eg
polyomavirus
papillomavirus
affect
checkpoint
control
prb
virus
ensur
product
host
enzym
requir
viral
replic
field
knipe
product
viral
protein
dna
virus
intermedi
larg
size
genom
divid
earli
late
phase
earli
prerepl
phase
nonstructur
protein
requir
dna
replic
translat
late
phase
late
structur
protein
need
assembl
translat
begin
viral
dna
replic
fig
depend
speci
virus
assembl
either
contact
cellular
membran
independ
membran
either
nucleu
cytoplasm
membraneindepend
rout
use
nonenvelop
virus
envelop
virus
eg
orthomyxovirus
herpesvirus
retrovirus
acquir
membran
envelop
intracellular
assembl
bud
cell
limit
step
nuclear
assembl
size
npc
larg
enough
transport
rna
import
protein
requir
assembl
nucleu
howev
npc
size
limit
transport
larger
assembl
therefor
virus
form
assembl
intermedi
nucleu
structur
export
cytoplasm
come
togeth
form
viral
particl
nuclear
export
specif
depend
presenc
nuclear
export
signal
ne
transport
protein
one
exampl
nonenvelop
icosahedr
viru
assembl
nucleu
adenoviru
assembl
studi
intens
due
potenti
use
gene
therapi
review
ahi
mittal
recent
data
suggest
upon
accumul
multipl
copi
adenovir
dsdna
genom
coordin
assembl
packag
occur
two
interlink
mechan
involv
capsid
protein
core
compon
condezo
san
assembl
occur
socal
peripher
replic
zone
assist
scaffold
protein
facilit
format
adenovir
particl
exclud
matur
virus
adenovirus
final
releas
upon
lysi
infect
host
cell
orthomyxovirus
herpesvirus
envelop
virus
assembl
nucleoprotein
nucleu
herpesvirus
packag
dsdna
genom
headtotail
concatem
assembl
icosahedr
procapsid
scaffold
protein
nucleu
review
heme
et
al
howev
subsequ
step
herpesviru
assembl
proceed
cytoplasm
preassembl
procapsid
larg
pass
npc
exit
nucleu
viral
proteindriven
vesicular
transport
across
nuclear
inner
membran
leaflet
thu
herpesviru
acquir
initi
envelop
inner
nuclear
membran
review
see
field
knipe
hellberg
et
al
next
herpesvir
membran
fuse
outer
nuclear
membran
nake
particl
releas
nucleu
cytosol
viru
acquir
tegument
protein
layer
capsid
envelop
protein
final
herpesviru
envelop
occur
golgi
membran
contain
viral
glycoprotein
field
knipe
preassembl
orthomyxovir
ribonucleoprotein
upon
export
nucleu
driven
plasma
membran
attach
electrostat
interact
matrix
protein
membran
phosphatidylserin
virion
assembl
simultan
bud
also
acquir
ha
na
membran
protein
poxvirus
undergo
even
complic
pathway
envelop
multipl
membran
acquir
erintermedi
compart
golgi
earli
endosom
moss
moss
membran
also
provid
poxvirus
membran
protein
virus
assembl
upon
interact
structur
protein
cellular
membran
target
membran
assembl
differ
accord
viru
type
flavivirus
assembl
surfac
er
upon
bud
er
lumen
immatur
particl
transport
tgn
virus
coronavirus
assembl
ergolgi
intermedi
compart
review
ujik
taguchi
assembl
bunyavirus
occur
concurr
replic
grna
segment
viru
factori
locat
along
golgi
guu
et
al
strandin
et
al
presenc
membran
glycoprotein
golgi
membran
determin
site
assembl
bunyaviru
particl
bud
golgi
lumen
similar
envelop
virus
numer
virus
includ
paramyxovirus
cox
plemper
orthomyxovirus
pohl
et
al
alphavirus
jose
et
al
rhabdovirus
okumura
harti
retrovirus
freed
assembl
underneath
cytoplasm
membran
facilit
assembl
provid
scaffold
function
viru
acquir
lipid
envelop
bud
across
plasma
membran
process
also
gain
envelop
glycoprotein
env
anchor
plasma
membran
hydrophob
transmembran
domain
env
reach
plasma
membran
cellular
secretori
pathway
upon
synthesi
er
subsequ
glycosyl
golgi
usual
specif
interact
viral
structur
protein
glycoprotein
requir
may
either
direct
mediat
interact
matrix
protein
eg
rna
virus
orthoand
paramyxovirus
rhabdovirus
retrovirus
includ
hiv
socal
morphogenet
ctype
also
assembl
plasma
membran
host
cell
interact
structur
polyprotein
precursor
gag
plasma
membran
usual
facilit
bipartit
signal
ntermin
domain
gag
ie
matrix
protein
compris
basic
patch
ntermin
link
myristoyl
residu
ad
cotransl
gag
contrast
ctype
assembl
membran
morphogenet
bdtype
retrovirus
assembl
pericentriolar
site
gag
polyprotein
transport
along
microtubul
dynein
molecular
motor
sfakiano
et
al
vlach
et
al
morphogenet
pathway
packag
grna
facilit
assembl
rna
virus
adopt
mechan
extens
rearrang
intracellular
membran
provid
milieu
viru
replic
assembl
mechan
effect
protect
dsrna
intermedi
degrad
host
cell
machineri
delgui
colombo
jackson
process
welldocu
polioviru
newli
form
membran
structur
exclus
serv
viru
product
variou
type
vesicl
form
upon
viral
infect
differ
role
viral
replic
rossignol
et
al
nonenvelop
mammalian
virus
reovirus
assembl
cytosol
socal
viroplasm
viral
factori
icosahedr
particl
consist
three
concentr
layer
encircl
segment
genom
dsdna
benavent
martinezcosta
jone
shah
et
al
rotaviru
seem
exempt
reoviru
famili
enter
endoplasm
reticulum
gain
outer
protein
shell
trask
et
al
numer
virus
assembl
polyprotein
precursor
must
specif
cleav
viral
proteas
gener
infecti
particl
mechan
irrevers
step
viru
life
cycl
ensur
equimolar
packag
structur
protein
proport
coassembl
viral
enzym
form
precursor
upon
proteolyt
releas
liber
protein
may
undergo
differ
traffick
pathway
fulfil
variou
function
viru
matur
chang
energi
interact
forc
among
interfac
requir
intracellular
assembl
immatur
particl
suitabl
viral
stabil
environ
disassembl
uncoat
genet
materi
replic
review
veesler
johnson
polioviru
autocatalyt
subsequ
viral
proteasemedi
cleavag
precursor
protein
allow
format
pentam
interact
grna
addit
cleavag
yield
requir
form
infecti
polioviru
particl
retrovirus
proteolyt
process
initi
autocatalyt
liber
viral
proteas
subsequ
cleav
polyprotein
trigger
major
structur
rearrang
viru
releas
viral
enzym
revers
transcriptas
integras
structur
protein
herpesvirus
matur
involv
proteolyt
process
scaffold
protein
recruit
tegument
protein
stabil
particl
mediat
interact
membran
envelop
gibson
tandon
mocarski
tandon
et
al
adenovirus
undergo
matur
process
involv
process
six
structur
compon
core
one
nonstructur
precursor
initi
replic
gdna
gaba
et
al
one
interest
featur
adenovir
matur
dna
requir
cofactor
proteas
activ
mean
matur
occur
particl
packag
gdna
mangel
san
flavivirus
form
icosahedr
particl
upon
bud
neutral
milieu
er
particl
transloc
acid
environ
transgolgi
network
ph
shift
result
disassembl
immatur
lattic
extens
rearrang
flavivir
particl
connect
exposur
viral
structur
glycoprotein
prm
specif
process
retrovirus
c
dna
virus
scheme
ac
modifi
ahlquist
follow
endocytosi
genom
rna
virus
may
directli
serv
mrna
translat
viru
encod
protein
among
protein
rnarepl
machineri
recruit
rna
membraneassoci
replic
complex
genom
rna
replic
use
rna
templat
transcrib
low
copi
number
amplifi
rna
packag
newli
assembl
virion
exit
host
cell
either
secret
cell
lysi
b
upon
viru
attach
core
contain
grna
viru
encod
rna
polymeras
deliv
cytoplasm
endocytosi
cytoplasm
transcript
rna
templat
provid
rna
serv
mrna
translat
viral
protein
dsrna
virus
rna
packag
new
core
undergo
matur
synthes
rna
dot
strand
acquir
surfac
protein
rna
virus
rna
strand
transcrib
genom
rna
cytoplasm
packag
new
virion
egress
cell
either
secret
cell
lysi
c
follow
fusion
viral
cell
plasma
membran
retrovir
core
releas
cytosol
rna
genom
transcrib
dsdna
viral
revers
transcriptas
concomitantli
uncoat
viral
core
ds
dna
transfer
nucleu
integr
host
cell
genom
viral
integras
follow
translat
retrovir
structur
enzymat
polyprotein
unsplic
grna
packag
immatur
particl
usual
assembl
plasma
membran
viral
particl
bud
cell
three
mechan
iiii
dna
virus
replic
shown
follow
entri
uncoat
dna
genom
transport
nucleu
product
earli
gene
regulatori
protein
transcript
factor
regul
synthesi
viral
enzym
eg
dna
polymeras
requir
genom
replic
express
late
gene
encod
structur
capsid
protein
cytosol
transport
nucleu
packag
preassembl
take
place
preassembl
procapsid
exit
nucleu
leav
cell
eg
herpesvirus
ii
uniqu
replic
cycl
hepat
b
viru
hbv
follow
entri
viral
particl
intern
endocytosi
nucleocapsid
releas
cytoplasm
genom
relax
circular
rcdna
transport
nucleu
convert
coval
close
circular
form
cccdna
serv
templat
transcript
pregenom
rna
pgrna
translat
core
protein
viral
polymeras
three
subgenom
mrna
use
translat
regulatori
envelop
protein
follow
viral
transcript
translat
hbv
core
protein
selfassembl
cytoplasm
viral
nucleocapsid
concurr
incorpor
pgrna
hbv
polymeras
pgrna
revers
transcrib
rcdna
within
nucleocapsid
nucleocapsid
contain
rcdna
either
reenter
nucleu
amplifi
cccdna
envelop
hbv
envelop
protein
endoplasm
reticulum
particl
secret
infect
hepatocyt
exocytosi
iii
upon
enter
cell
replic
transcript
translat
take
place
entir
cytoplasm
within
discret
juxtanuclear
site
call
viru
factori
eg
poxvirus
adapt
ahlquist
p
parallel
among
positivestrand
rna
virus
reversetranscrib
virus
doublestrand
rna
virus
nat
rev
microbiol
cellular
proteas
furin
transgolgi
network
liber
globular
head
prm
remain
attach
low
ph
releas
viru
enter
neutral
bodi
fluid
rey
et
al
one
frequent
use
mechan
releas
nonenvelop
envelop
virus
lysi
infect
cell
simplest
releas
mechan
although
transit
lysi
latent
infect
delic
regul
aneja
yuan
leve
roth
schmiedel
et
al
howev
virus
usual
lysogen
may
also
use
altern
releas
pathway
bird
kirkegaard
includ
nonlyt
spread
virus
mediat
vesicl
observ
polioviru
bird
kirkegaard
jackson
et
al
coxsackieviru
alirezaei
et
al
hepat
viru
anoth
possibl
vesicl
releas
cell
infect
rna
virus
contain
nake
viral
grna
grnacontain
vesicl
function
infecti
agent
transfer
anoth
cell
bird
kirkegaard
standard
way
envelop
virus
leav
host
cell
bud
includ
membran
extrus
separ
viral
cellular
membran
socal
pinch
lipid
envelop
layer
acquir
viral
particl
bud
plasma
membran
protect
viru
particl
three
basic
mechan
bud
mediat
envelop
glycoprotein
e
protein
coronavirus
ii
independ
glycoprotein
viral
structur
protein
trigger
extrus
plasma
membran
retrovir
bud
strong
interact
gag
ntermin
domain
matrix
protein
plasma
membran
induc
bulg
membran
iii
requir
interact
viral
glycoprotein
capsid
membran
extrus
alphavirus
final
step
result
separ
viru
cell
surfac
pinch
particl
control
process
involv
viral
protein
domain
cellular
factor
process
virus
appar
use
cellular
machineri
similar
use
last
step
cell
divis
releas
daughter
cell
call
endosom
sort
complex
requir
transport
escrt
review
campsteijn
et
al
hurley
olmo
carlton
scourfield
martinserrano
direct
interact
numer
viral
domain
escrt
complex
subunit
identifi
bieniasz
retrovirus
short
specif
amino
acid
sequenc
ptap
psap
interact
escrt
compon
interact
hiv
escrt
protein
alix
wellknown
freed
fujii
et
al
gomez
hope
howev
mechan
also
adopt
virus
interact
escrt
compon
filovirus
han
et
al
jasenoski
kawaoka
liu
harti
interact
escrt
protein
also
report
vesicular
stomat
viru
luyet
et
al
rhabdoviru
taylor
et
al
arenavirus
ziegler
et
al
picornavirus
paramyxovirus
park
et
al
hepat
c
viru
repres
flaviviru
famili
falcon
et
al
typic
releas
pathway
use
virus
may
vari
condit
exampl
chronic
infect
numer
virus
use
altern
celltocel
transmiss
may
help
viru
avoid
host
neutral
hulo
et
al
syncytium
format
hivinduc
cell
fusion
recogn
earli
callahan
anoth
type
celltocel
transmiss
tight
junction
shown
hiv
et
al
wang
et
al
murin
leukemia
viru
sherer
et
al
receptor
tight
junction
specif
recogn
hepat
c
viru
carloni
et
al
ploss
et
al
reoviru
barton
et
al
identifi
virus
abl
modifi
cellular
pathway
reprogram
synthesi
metabol
lipid
membran
compartment
transmiss
evad
cellular
defens
mechan
mazzon
mercer
despit
gener
understand
polioviru
spread
cellular
lysi
recent
found
may
also
transfer
cell
autophagydepend
mechan
call
autophagosomemedi
exit
without
lysi
bird
kirkegaard
bird
et
al
lai
et
al
richard
jackson
similar
mechan
describ
varicellazost
viru
human
cytomegaloviru
grose
et
al
meier
grose
poxvirus
encod
sever
protein
block
apoptot
cellular
respons
presenc
dsdna
cytoplasm
allow
celltocel
passag
poxvirus
mechan
known
apoptot
mimicri
amara
mercer
nichol
et
al
process
envelop
virus
expos
surfac
phosphatidylserin
mimic
apoptot
bodi
cell
macropinocytos
either
dendrit
cell
macrophag
mercer
heleniu
among
plethora
compound
design
inhibit
infecti
virus
approv
clinic
use
de
clercq
de
clercq
li
nevertheless
effect
antivir
drug
market
sever
decad
antiinfluenza
viru
drug
amantadin
market
trade
name
symmetrel
dupont
approv
burroughswellcom
introduc
acyclovir
inhibitor
herpesvirus
remark
specif
connect
activ
viral
thymidin
kinasecatalyz
phosphoryl
howev
due
develop
drug
resist
number
virus
especi
rna
virus
continu
need
design
test
new
inhibitor
prefer
target
differ
step
viral
life
cycl
provid
insight
world
biochem
cellbas
assay
develop
test
antivirot
target
variou
step
viral
life
cycl
differ
type
assay
includ
cellcel
fusion
assay
cellviru
fusion
assay
pseudotyp
viral
particl
vitro
biochem
assay
develop
screen
inhibitor
viral
entri
envelop
virus
entri
initi
fusion
viral
envelop
target
cellular
membran
entri
mechan
welldescrib
mediat
env
glycoprotein
consist
transmembran
surfac
subunit
bind
cellular
receptor
one
two
coreceptor
trigger
refold
promot
fusion
viral
cellular
membran
refold
involv
oligomer
extracellular
nand
ctermin
heptad
repeat
hr
domain
lead
format
bundl
review
melikyan
jiang
et
al
establish
vitro
system
quantifi
format
bundl
jiang
et
al
system
bundl
form
mix
equimolar
concentr
peptid
deriv
nand
chr
region
elisa
use
monoclon
antibodi
specif
recogn
bind
epitop
form
bundl
individu
peptid
enabl
screen
compound
prevent
format
fusionact
ht
fusion
inhibitor
method
modifi
use
fluorescencelink
immunosorb
assay
flisa
chr
peptid
replac
fitcconjug
chr
peptid
boyerchatenet
et
al
cellbas
assay
routin
use
screen
viral
entri
inhibitor
high
throughput
format
develop
screen
fusion
inhibitor
cellcel
fusion
assay
involv
two
type
cell
effector
cell
stabli
bradley
et
al
induc
herschhorn
et
al
ji
et
al
express
hivenv
glycoprotein
target
cell
express
either
cocultiv
cell
lead
envmedi
cell
membran
fusion
result
format
multinucl
syncytia
membran
fusion
induc
express
report
protein
luciferas
herschhorn
et
al
ji
et
al
bradley
et
al
one
assay
enabl
determin
effici
specif
fusion
inhibitor
herschhorn
et
al
approach
use
effector
cell
express
env
renilla
luciferas
rluc
report
protein
use
induc
tetracyclinecontrol
transactiv
tta
target
cell
express
receptor
coreceptor
contain
firefli
luciferas
fluc
report
gene
control
ttarespons
promot
upon
fusion
effector
target
cell
tta
enter
target
cell
activ
express
fluc
report
inhibit
fusion
cellular
membran
determin
decreas
fluc
luminesc
inhibitor
specif
measur
rluc
activ
herschhorn
et
al
base
cellcel
fusion
method
use
computercontrol
digit
imag
analysi
system
automat
quantit
modifi
method
develop
screen
inhibitor
target
merscov
protein
lu
et
al
test
potenti
fusion
inhibitor
effector
cell
stabli
express
merscov
spike
protein
egfp
use
mediat
fusion
target
cell
express
receptor
lu
et
al
virionbas
fusion
assay
anoth
categori
cellbas
fusion
assay
one
approach
base
product
chimer
virion
carri
chimer
protein
blamvpr
chimer
hiv
releas
cell
cultur
media
isol
ultracentrifug
use
infect
target
cell
entri
virion
cytoplasm
detect
cleavag
fluoresc
substrat
fluoresc
shift
correspond
fusion
efficaci
measur
fluoresc
microscopi
flow
cytometri
fluorometr
plate
reader
cavroi
et
al
cavroi
et
al
cavroi
et
al
modif
assay
construct
pseudotyp
virion
env
replac
ebola
viru
glycoprotein
gp
also
describ
yonezawa
et
al
tschern
et
al
develop
approach
monitor
viral
entri
use
blam
report
tschern
et
al
assay
use
influenza
viruslik
particl
vlp
bear
influenza
membran
protein
hemagglutinin
neuraminidas
blam
tag
influenza
matrix
protein
incorpor
vlp
deliv
target
cell
upon
releas
blam
detect
flow
cytometri
microscop
fluorometr
rapid
cellbas
ht
method
develop
assess
sarscov
entri
inhibitor
zhou
et
al
dual
envelop
pseudovirion
dep
assay
employ
two
hiv
pseudovirus
one
encod
envelop
protein
target
viru
firefli
luciferas
second
encod
control
unrel
viral
envelop
protein
renilla
luciferas
report
express
determin
dualglo
luciferas
assay
system
promega
inclus
unrel
envelop
protein
greatli
reduc
fals
posit
hit
zhou
et
al
method
use
screen
compound
inhibit
entri
filovirus
includ
ebola
viru
similar
approach
employ
four
pseudotyp
hiv
virus
carri
marburg
viru
glycoprotein
hemagglutinin
neuraminidas
isol
influenza
viru
ebolaviru
zair
envelop
glycoprotein
lassa
viru
envelop
glycoprotein
use
entri
inhibitor
screen
screen
identifi
multipl
compound
potent
inhibitori
activ
entri
marburg
ebola
virus
human
cancer
cell
line
confirm
antiebola
activ
human
primari
cell
pseudotyp
viral
assay
use
screen
entri
inhibitor
sarscov
ebola
hendra
nipah
virus
establish
infect
glycoprotein
virus
must
process
host
intracellular
lysosom
proteas
cathepsin
l
catl
ht
result
identif
sever
inhibitor
block
cleavag
viral
glycoprotein
catl
elshabrawi
et
al
recent
develop
antihbv
therapeut
limit
lack
vitro
infect
system
sever
aspect
hbv
life
cycl
elucid
use
vitro
product
hbv
particl
transfect
human
hepatoma
cell
line
recombin
hbv
dna
establish
hepatoma
cell
line
entir
hbv
genom
integr
cell
line
ladner
et
al
sell
et
al
sureau
et
al
addit
differenti
human
phh
gripon
et
al
tupaia
belangeri
glebe
et
al
hepatocyt
heparg
cell
line
exhibit
hepatocytelik
characterist
also
support
hbv
replic
gripon
et
al
identif
sodium
taurochol
cotransport
polypeptid
ntcp
hbv
receptor
yan
et
al
open
possibl
use
ntcpcomplement
cell
studi
hbv
replic
mechan
also
ht
inhibitor
yan
et
al
infect
competit
assay
hbv
particl
isol
use
infect
heparg
phh
cell
preincub
hbv
envelop
proteinderiv
peptid
test
potenti
activ
block
hbv
infect
twelv
day
infect
viral
rna
quantifi
northern
blot
gripon
et
al
gripon
et
al
use
assay
research
identifi
peptid
specif
prevent
hbv
hdv
entri
heparg
phh
cell
line
gripon
et
al
primari
cultur
tupaia
hepatocyt
glebe
et
al
cell
vivo
et
al
petersen
et
al
volz
et
al
recent
phase
iia
clinic
trial
firstinclass
entri
inhibitor
myrcludexb
function
ntcp
inhibitor
promisingli
complet
bogomolov
et
al
develop
cell
cultur
system
produc
hcv
pseudoparticl
hcvpp
infecti
hcv
particl
hcvcc
shed
light
hcv
interact
enabl
discoveri
antivir
drug
vaccin
colpitt
et
al
hcvpp
consist
hcv
glycoprotein
envelop
retrovir
particl
packag
gfp
mrna
assembl
bartosch
et
al
entri
effici
hcvpp
quantifi
fac
analysi
number
gfpposit
cell
use
screen
system
led
discoveri
triazin
deriv
block
entri
hcv
baldick
et
al
product
hcvcc
robust
system
gener
infecti
hcv
cell
kato
et
al
zhong
et
al
antihcv
activ
hundr
compound
approv
wide
varieti
indic
determin
immunochem
antihcv
antibodi
plate
format
thirti
compound
display
antihcv
activ
direct
hcv
entri
gastaminza
et
al
major
virus
enter
cell
endocytosi
unfortun
suitabl
experiment
techniqu
endosom
handl
make
difficult
studi
earli
step
viral
life
cycl
uncoat
capsid
disassembl
virus
enter
cell
direct
membran
fusion
except
sever
method
avail
monitor
quantifi
hiv
uncoat
review
recent
campbel
hope
campbel
hope
discuss
briefli
two
main
techniqu
use
assay
ultracentrifug
util
specif
cellular
restrict
factor
vitro
corest
assay
base
ultracentrifug
releas
virion
deterg
layer
viral
membran
dissolv
sucros
gradient
viral
core
concentr
shah
aiken
fate
capsid
assay
use
ultracentrifug
sucros
cushion
separ
core
whole
cell
lysat
prepar
shortli
infect
stremlau
et
al
csawashout
assay
involv
specif
cellular
factor
trimcyclophilin
restrict
infect
bind
capsid
core
cyclosporin
csa
effect
turn
restrict
hulm
et
al
recent
novel
entryunco
assay
eurt
altern
blamvpr
describ
section
report
da
silva
santo
et
al
quantifi
protein
product
virionpackag
mrna
report
upon
uncoat
method
monitor
uncoatingdisassembl
capsid
influenza
viru
enter
cell
endocytosi
also
base
ultracentrifug
stauffer
et
al
purifi
virion
separ
use
veloc
gradient
centrifug
twolay
glycerol
gradient
similar
vitro
core
stabil
assay
hiv
sediment
virus
migrat
detergentcontain
layer
gradient
dissolv
membran
releas
viral
core
moreov
modif
detergentcontain
glycerol
layerfor
exampl
lower
ph
chang
ionic
strength
ad
put
viral
uncoat
factorsen
studi
factor
compound
affect
viral
uncoat
vitro
depend
viru
type
either
dna
rna
polymeras
replic
viral
genom
thu
enzym
play
key
role
viral
life
cycl
revers
transcriptas
rnadepend
dna
polymeras
retroand
hepadnavirus
uniqu
among
nucleic
acid
polymeras
despit
differ
mechan
viral
replic
polymeras
essenti
virus
excel
target
antivir
therapi
polymeras
inhibitor
repres
vast
major
clinic
approv
antivir
drug
follow
proteas
inhibitor
immunostimul
entri
inhibitor
integras
inhibitor
review
de
clercq
li
polymeras
continu
prefer
target
newli
design
inhibitor
clercq
de
clercq
li
polymeras
inhibitor
may
nucleosid
nucleotid
analog
pyrophosph
analog
nonnucleosid
alloster
inhibitor
de
clercq
li
nonspecif
approach
plaqu
assay
initi
use
monitor
effect
polymeras
inhibitor
tino
et
al
tisdal
et
al
activ
inhibitor
also
evalu
base
abil
prevent
cytopath
effect
viru
zhang
et
al
straightforward
assay
involv
measur
incorpor
radiolabel
nucleotid
directli
reflect
polymeras
activ
coat
et
al
hirashima
et
al
joyc
includ
ht
method
use
homopolymer
polycytidyl
acid
h
gtp
amraiz
et
al
altern
pyrophosph
releas
polymeras
reaction
measur
luminometr
combin
primer
extens
commerci
piper
assay
malvezzi
et
al
pyrophosph
anion
also
detect
dnaattach
magnet
nanoparticl
tong
et
al
quantum
dot
chai
et
al
frequent
use
fluoresc
method
avoid
use
radiochem
method
exploit
fluoresc
label
dsdna
bind
dye
like
sybr
green
picogreen
driscol
et
al
holden
et
al
zipper
et
al
fret
two
nucleotid
schwartz
quak
weiss
numer
kit
quantif
product
dna
rna
polymeras
includ
revers
transcriptas
commerci
avail
bustin
quantit
realtim
pcr
prefer
method
monitor
activ
dna
polymeras
cellular
well
viral
presenc
inhibitor
beadl
et
al
zweitzig
et
al
quantit
realtim
reversetranscript
pcr
becom
standard
screen
inhibitor
viral
rna
polymeras
okon
et
al
pelliccia
et
al
zhang
et
al
white
et
al
describ
ht
method
use
microfluid
apparatu
combin
digit
pcr
singlecel
analysi
white
et
al
method
fluoresc
label
templat
also
serv
primer
due
stem
format
emit
measur
polar
signal
upon
bind
polymeras
extens
mesta
et
al
assay
use
ht
inhibitor
polioviru
rna
polymeras
campagnola
et
al
avail
viral
genom
modifi
report
gene
use
cellbas
luminesc
fluoresc
screen
viral
inhibitor
beadl
et
al
edward
et
al
fenaux
et
al
feng
et
al
lo
et
al
madhvi
et
al
wang
et
al
approach
extend
screen
inhibitor
enzym
aptamerbas
approach
dna
templat
encod
rna
interest
join
fluoresc
modul
ribozym
sequenc
transcrib
fluoresc
modul
releas
detect
et
al
hcv
use
rnadepend
rna
polymeras
rdrp
uniqu
cellbas
assay
monitor
hcv
rna
polymeras
activ
base
innat
immun
signal
molecul
retion
acidinduc
gene
product
rigi
develop
ranjithkumar
et
al
rigilik
receptor
cytosol
protein
recogn
viral
rna
induc
product
proinflammatori
cytokin
interferonactiv
gene
jensen
thomsen
rigi
trigger
cytokin
product
stimul
variou
viral
rna
differ
famili
includ
flavivirida
paramyxovirida
rhabdovirida
orthomyxovirida
arenavirida
well
ebola
viru
rna
jensen
thomsen
assay
base
recognit
hcv
rna
produc
activ
rigi
follow
rigimedi
activ
firefli
luciferas
express
control
interferon
b
promot
renilla
luciferas
express
use
normal
transfect
efficaci
viral
grna
rna
virus
modifi
end
cap
structur
may
either
acquir
host
cell
mrna
eg
influenza
viru
newli
synthes
eg
flavivirus
methyl
viral
grna
mimic
cellular
mrna
cap
structur
enhanc
chanc
viru
escap
cellular
defens
mechan
also
increas
effici
translat
viral
protein
virusspecif
methyltransferas
thu
promis
therapeut
target
virusencod
methyltransferas
identifi
character
flavivirus
zika
viru
coutard
et
al
duan
et
al
munjal
et
al
zhao
et
al
west
nile
viru
dengu
viru
dong
et
al
rhabdovirus
vesicular
stomat
viru
vsv
rahmeh
et
al
coronavirus
sar
wang
et
al
ronivirus
zeng
et
al
flavivirus
ntermin
part
methyltransferas
catalyz
cap
format
via
guanin
ribos
methyl
end
grna
cterminu
enzym
respons
rna
polymeras
activ
ray
et
al
zhao
et
al
ctermin
part
sar
protein
exhibit
guanin
activ
form
grna
cap
exoribonucleas
activ
nterminu
enhanc
fidel
viral
replic
case
et
al
minskaia
et
al
vsv
methyltransferas
activ
resid
conserv
region
vi
multifunct
larg
polymeras
protein
li
et
al
et
al
cellular
methyltransferas
regul
viral
infect
shown
herp
simplex
viru
epigenet
control
involv
viral
latenc
cliff
wilson
inhibit
human
histon
methyltransferas
histonelysin
nmethyltransferas
arbuckl
et
al
lysinespecif
induc
antivir
signal
pathway
liang
et
al
inhibitori
effect
histon
demethylas
activ
demonstr
human
cytomegaloviru
gan
et
al
herp
simplex
viru
hill
et
al
liang
et
al
activ
purifi
recombin
methyltransferas
determin
measur
methyl
byproduct
sadenosyl
homocystein
sah
use
commerci
avail
kit
one
assay
convers
sadenosyl
methionin
sam
sah
monitor
luminometr
via
luciferas
reaction
measur
atp
gener
sequenc
reaction
reagent
promega
methyltransferas
kit
cisbio
bioassay
base
competit
produc
sah
fluoresc
label
sah
tracer
bind
terbium
cryptatelabel
antisah
antibodi
decreas
fret
tracer
antibodi
evalu
elisa
use
antibodi
use
quantifi
methyl
immobil
cytosinerich
dna
substrat
eg
dna
methyltransferas
activityinhibit
assay
kit
epigentek
method
modifi
homogen
time
resolv
fret
degorc
et
al
screen
librari
inhibitor
sarscov
flavivir
human
cap
screen
radioact
assay
use
hlabel
sam
synthet
rna
h
methyl
transfer
onto
deae
filterbound
rna
measur
scintil
multipl
wash
remov
unincorpor
hsam
altern
vitro
transcript
carri
use
hsam
radioact
label
product
resolv
thinlay
chromatographi
develop
use
phosphorimag
li
et
al
yeast
cellbas
method
establish
base
find
coronaviru
methyltransferas
function
replac
methyltransferas
essenti
yeast
viabil
sun
et
al
method
sun
et
al
construct
recombin
yeast
produc
viral
methyltransferas
instead
yeast
one
sun
et
al
strain
use
ht
methyltransferas
inhibitor
activ
neg
correl
cell
densiti
h
incub
virusencod
atpasedriven
helicas
identifi
numer
human
pathogen
helicas
sever
rna
virus
character
includ
helicas
flavivirus
dengu
viru
hcv
west
nile
viru
yellow
fever
viru
japanes
enceph
viru
cao
et
al
gu
rice
jain
et
al
lin
et
al
nedjadi
et
al
wu
et
al
sar
mer
coronavirus
encod
helicas
activ
adedeji
lazaru
hao
et
al
seybert
et
al
semliki
forest
viru
repres
member
togaviru
famili
helicas
activ
encod
ntermin
domain
protein
helicas
also
common
dna
virus
includ
poxvirus
includ
vaccinia
viru
helicaseprimas
bayliss
smith
hutin
et
al
protein
bovin
papilloma
viru
yang
et
al
larg
tumor
antigen
stahl
et
al
helicas
appear
attract
target
antivir
drug
briguglio
et
al
frick
reynold
et
al
develop
compound
challeng
cytotox
bioavail
issu
kwong
et
al
tradit
method
monitor
activ
rna
helicas
use
radioact
label
dsrna
substrat
follow
unwind
reaction
electrophoret
separ
nondenatur
page
ss
reaction
product
detect
autoradiograph
adedeji
et
al
utama
et
al
determin
whether
inhibitor
affect
bind
helicas
nucleic
acid
standard
gel
mobil
shift
assay
usual
use
adedeji
et
al
helicas
activ
fuel
atp
hydrolysi
thu
inhibit
atpas
activ
becam
anoth
possibl
antivir
strategi
atpas
activ
determin
either
decreas
atp
format
adp
use
commerci
avail
fluoresc
antiadp
antibodi
inorgan
pyrophosph
phosphat
releas
atp
hydrolysi
form
molybdophosph
complex
measur
colorimetr
use
malachit
green
quinaldin
red
rhodamin
b
baykov
et
al
debruyn
miyata
et
al
lightscatt
oshima
et
al
colorimetr
method
miniatur
ht
zuck
et
al
absorbancebas
assay
also
convert
ht
method
base
fluoresc
quench
color
quinaldin
red
complex
altern
method
employ
europiumtetracyclin
complex
luminesc
determin
inorgan
phosphat
wolfbei
complex
coupl
enzym
colorimetr
assay
maltos
phosphorylas
glucos
oxidas
horseradish
peroxidas
use
ht
atpas
inhibitor
avila
et
al
assay
luminesc
fluoresc
screen
atpas
activ
includ
immunochem
method
use
fluoresc
label
antiadp
antibodi
review
shadrick
colleagu
shadrick
et
al
radioact
method
use
p
atp
amp
product
separ
unreact
atp
thinlay
chromatographi
polyethyleneiminecellulos
visual
autoradiograph
adedeji
et
al
sever
research
group
describ
fluoresc
assay
identifi
inhibitor
target
sarscov
helicas
adedeji
et
al
cho
et
al
et
al
substrat
usual
dsdna
oligonucleotid
consist
fluoresc
label
strand
anneal
complementari
strand
carri
quencher
approach
also
adapt
realtim
determin
rna
helicas
activ
hcv
tani
et
al
assay
ssdna
captur
strand
complementari
strand
carri
quencher
use
prevent
reanneal
unwound
duplex
recent
colorimetr
assay
monitor
helicas
activ
use
dnaconjug
gold
nanoparticl
develop
deka
et
al
method
base
shift
optic
properti
nanoparticl
due
dna
unwind
allow
simpl
screen
inhibitor
activ
dsdna
melt
curv
determin
spectrophotometr
nm
nm
even
nake
eye
anoth
fluoresc
ht
dengu
viru
helicas
inhibitor
measur
unwind
doublelabel
molecular
beacon
basavannacharya
vasudevan
approach
involv
graphen
oxidebas
fluoresc
monitor
viral
helicas
activ
review
jang
et
al
gquadruplexbas
method
labelfre
determin
hcv
helicas
activ
measur
chang
luminesc
transit
metal
complex
dna
upon
helicasemedi
quadruplex
melt
leung
et
al
protein
tyrosin
kinas
protein
serinethreonin
st
kinas
found
virus
tyrosin
kinas
function
wellunderstood
connect
oncogen
retrovirus
review
retrovir
oncogen
see
vogt
contrast
tyrosin
kinas
oncogen
virus
rou
sarcoma
viru
src
tyrosin
kinas
viral
st
kinas
share
littl
homolog
cellular
enzym
exclus
encod
larg
dna
virus
eg
herpesvirus
play
import
role
viral
virul
help
viru
escap
defens
mechan
regul
cytokin
signal
pathway
jacob
et
al
sato
et
al
autophosphoryl
transphosphoryl
activ
mimic
cellular
cyclindepend
kinas
exampl
viral
kinas
phosphoryl
translat
elong
factor
delta
jacob
et
al
kawaguchi
kato
herpesvirus
encod
st
protein
kinas
st
kinas
describ
alphaherpesviru
subfamili
kato
kawaguchi
kato
addit
protein
kinas
hsv
encod
thymidin
kinas
unlik
cellular
thymidin
kinas
hsv
thymidin
kinas
wide
substrat
specif
includ
pyrimidin
purin
phosphon
analog
eg
acyclovir
ganciclovir
penciclovir
de
clercq
li
bodi
ganciclovir
phosphoryl
cellular
kinas
penciclovir
acyclovir
virusencod
thymidin
kinas
activ
nucleosid
triphosph
form
drug
inhibit
viral
dna
synthesi
de
clercq
li
kokori
black
cellular
protein
kinas
appear
support
viral
replic
exampl
pololik
kinas
induc
earli
stage
influenza
viru
life
cycl
pohl
et
al
human
protein
kinas
c
regul
assembl
ribonucleoprotein
complex
influenza
viru
mondal
et
al
inhibitor
abelson
tyrosineprotein
kinas
activ
sar
mer
coronavirus
coleman
et
al
sever
vitro
approach
use
determin
kinas
activ
well
activ
kinas
inhibitor
analys
cellular
phosphoproteom
sometim
accompani
phosphopeptid
enrich
becom
standard
determin
kinas
activ
lea
simeonov
meyer
et
al
vyse
et
al
assay
use
assess
impact
inhibitor
overal
phosphoproteom
mammalian
cell
although
method
provid
complex
inform
overal
array
kinas
phosphatas
cell
olsen
et
al
applic
screen
inhibitor
singl
viral
kinas
purpos
vitro
assay
recombin
kinas
develop
review
see
includ
ht
fluoresc
method
zegzouti
et
al
replac
radioact
techniqu
use
p
atp
sanghera
et
al
mass
spectrometr
analysi
also
use
identifi
vitro
kinas
inhibitor
analys
synthet
peptid
protein
phosphataseand
heattreat
tissu
sampl
dephosphoryl
protein
inactiv
enzym
respect
subject
kinas
treatment
presenc
inhibitor
huang
et
al
meyer
et
al
xue
et
al
recombin
kinas
activ
presenc
inhibitor
quantifi
atp
consumpt
adp
product
phosphoryl
reaction
numer
commerci
kit
method
monitor
bind
inhibitor
phagedisplay
kinas
ligand
competit
assay
fabian
et
al
fluoresc
method
includ
fret
fluoresc
polar
intens
endpoint
measur
lifetim
imag
fluoresc
includ
fluoresc
biosensor
zhang
allen
review
elsewher
sulfonamidooxin
label
peptid
use
chromophor
bind
mg
upon
phosphoryl
emit
chelationenhanc
fluoresc
devkota
et
al
et
al
kinasecatalyz
phosphoryl
fluoresc
peptid
promot
bind
metalco
nanoparticl
decreas
mobil
enhanc
measur
fluoresc
polar
lea
simeonov
sportsman
et
al
tbiii
complex
phosphotyrosin
induc
fluoresc
emiss
wang
et
al
may
use
evalu
protein
tyrosin
kinas
activ
akiba
et
al
sumaoka
et
al
fluoresc
polar
method
also
use
drug
screen
review
hall
et
al
altern
immunochem
method
use
antibodi
specif
phosphoryl
amino
acid
phosphotyrosin
li
et
al
youngren
et
al
phosphoserin
phosphothreonin
antibodi
use
detect
protein
peptid
phosphoryl
western
blot
elisa
immunoprecipit
phosphoryl
protein
mass
spectrometrybas
analysi
et
al
zhang
et
al
eleg
approach
limit
falseposit
hit
screen
specif
kinas
inhibitor
base
situ
proxim
ligat
assay
use
antibodi
target
protein
antiphosphotyrosin
antibodi
leuchowiu
et
al
antibodi
coupl
oligonucleotid
brought
togeth
due
antibodi
bind
enzymat
ligat
replic
roll
circl
amplif
form
long
linear
tandem
repeat
sequenc
detect
complementari
fluoresc
oligonucleotid
addit
protein
kinas
lipid
kinas
target
antivir
one
exampl
sphingosin
kinas
affect
replic
dengu
viru
aloia
et
al
activ
determin
measur
product
plabel
sphingosin
p
atp
clark
et
al
pitman
et
al
retrovir
integras
inhibitor
new
type
approv
new
type
inhibitor
impos
emerg
drugresist
mutant
hiv
integras
activ
integras
inhibitor
drug
resist
discuss
detail
elsewher
andrak
skalka
anstett
et
al
hajimahdi
zarghi
liao
et
al
podani
et
al
thierri
et
al
method
assess
two
major
activ
integraseend
process
revers
transcript
product
join
target
chromosom
dnahav
review
detail
sever
group
engelman
cherepanov
marchand
et
al
merkel
et
al
initi
method
use
radioact
label
dna
oligonucleotid
compris
termin
cisact
sequenc
linear
viral
dna
requir
integr
join
process
strand
strand
selfintegr
supplement
target
dna
analyz
page
katz
et
al
katzman
et
al
less
timeconsum
nonradioact
method
involv
timeresolv
fluoresc
anisotropi
measur
use
oligonucleotid
fluoresc
label
termin
gt
dinucleotid
assay
monitor
bind
integras
substrat
well
subsequ
reaction
chang
anisotropi
guiot
et
al
altern
yield
process
join
reaction
measur
upon
separ
radioact
label
product
rest
dna
molecul
use
adsorpt
peicellulos
muller
et
al
realtim
ht
method
measur
fluoresc
emiss
result
remov
dinucleotid
label
quencher
integras
et
al
han
et
al
describ
fluoresc
method
screen
molecul
inhibit
bind
integras
viral
dna
method
evalu
integras
strand
transfer
reaction
modifi
highthroughput
format
use
magnet
bead
et
al
streptavidinco
micropl
john
et
al
method
assess
strand
transfer
timeresolv
fret
europiumstreptavidinlabel
substrat
optim
plate
format
wang
et
al
hbv
capsid
protein
build
block
viral
core
surround
viral
nucleic
acid
pregenom
rna
pgrna
revers
transcriptas
hbv
core
icosahedr
form
copi
capsid
protein
dimer
vitro
ht
hbv
core
assembl
inhibitor
use
modifi
hbv
capsid
protein
describ
stray
et
al
capsid
protein
modifi
delet
nucleic
acid
bind
domain
dispens
capsid
assembl
ntermin
assembl
domain
alon
use
assay
fluoresc
label
hbv
capsid
protein
cystein
residu
dispens
assembl
replac
alanin
uniqu
cystein
residu
ctermin
join
assembl
domain
label
fluoresc
bodipyfl
dye
assembl
capsid
protein
dimer
bring
residu
close
togeth
result
fluoresc
selfquench
follow
incub
label
hbv
protein
inhibitor
fluoresc
measur
black
microtit
plate
develop
vitro
assembl
system
contribut
greatli
current
understand
structur
retrovir
particl
mechan
virion
format
system
also
becam
base
sever
high
throughput
assay
screen
assembl
inhibitor
last
year
number
vitro
assembl
assay
establish
mainli
campbel
et
al
campbel
rein
ehrlich
et
al
gross
et
al
lanman
et
al
masonpf
monkey
viru
bohmova
et
al
klikova
et
al
rumlovaklikova
et
al
rumlovaklikova
et
al
ulbrich
et
al
rou
sarcoma
viru
vogt
purdi
et
al
purdi
et
al
murin
leukemia
viru
dolez
et
al
hadravova
et
al
cheslock
et
al
ht
assay
inhibitor
assembl
includ
sever
method
use
purifi
ca
canc
protein
one
turbidimetr
assay
base
observ
direct
dilut
capsid
protein
ca
highsalt
solut
nacl
lead
format
tubular
structur
tube
format
accompani
increas
light
scatter
assembl
detect
increas
turbid
rate
turbid
chang
proport
rate
assembl
lanman
et
al
method
publish
lemk
et
al
exploit
affin
nucleocapsid
nc
short
tgrich
deoxyribooligonucleotid
use
scaffold
lemk
et
al
arrang
enabl
ca
assembl
much
lower
protein
salt
concentr
turbidimetr
assay
lanman
et
al
biotinlabel
bound
surfac
neutravidinco
microtit
well
plate
nucleat
assembl
complex
canc
solubl
fluoresceinlabel
fluoresc
measur
wash
remov
unbound
unassembl
materi
captur
assembl
product
lemk
et
al
similarli
faith
assay
use
dualli
label
oligonucleotid
tqon
howev
case
ssdna
oligonucleotid
tqon
label
report
dye
fluorescein
fam
well
black
hole
quencher
bhq
thu
emit
fluoresc
assembl
reaction
trigger
mix
canc
gagtrunc
assemblycompet
version
tqon
follow
incub
tqon
incorpor
particl
exonucleas
ad
degrad
unbound
tqon
coassembl
tqon
protect
cleavag
degrad
free
unbound
tqon
exoi
result
separ
fam
quencher
emit
fluoresc
measur
hadravova
et
al
phage
display
employ
screen
peptid
inhibitor
assembl
sticht
et
al
commerci
librari
phage
present
random
peptid
analyz
specif
bind
purifi
ca
canc
protein
specif
bound
phage
sequenc
correspond
peptid
chemic
synthes
retest
vitro
assembl
assay
gross
et
al
late
retrovir
life
cycl
grna
incorpor
nascent
particl
assembl
plasma
membran
nc
contain
two
zincfing
domain
respons
specif
bind
grna
screen
compound
would
prevent
ncrnadna
interact
ht
system
consist
two
sequenti
screen
develop
breuer
et
al
primari
screen
use
fluoresc
polar
fp
secondari
one
use
differenti
scan
fluorimetri
dsf
combin
order
two
techniqu
select
first
identifi
compound
disrupt
interact
dna
nc
identifi
compound
bind
nc
secondari
screen
rapid
simpl
turbidimetr
method
develop
screen
inhibitor
assembl
hcv
core
protein
fromentin
et
al
vitro
assembl
reaction
two
compon
ntermin
part
hcv
core
protein
correspond
minim
assembl
compet
domain
rna
correspond
fulllength
hcv
use
assembl
hcv
nucleocapsidlik
particl
initi
mix
purifi
protein
nucleic
acid
assembl
process
monitor
measur
turbid
nm
numer
virus
includ
picornavirus
retrovirus
alphavirus
flavivirus
encod
proteas
essenti
virul
major
viral
proteas
specif
cleav
viral
polyprotein
precursor
liber
function
protein
virion
viral
proteas
papainlik
proteas
coronavirus
also
reprogram
cellular
signal
pathway
includ
ubiquitin
mechan
interferon
control
respons
prevent
degrad
viral
compon
clementz
et
al
frieman
et
al
randow
lehner
xing
et
al
numer
virus
includ
papillomavirus
bronnimann
et
al
buck
et
al
retrovirus
hallenberg
et
al
use
also
host
cell
proteas
mainli
furin
trim
envelop
surfac
protein
trigger
conform
chang
requir
interact
cellular
receptor
membran
fusion
envelop
virus
virus
use
proteas
furin
modul
infect
shown
virus
enter
airway
epitheli
cell
review
laport
naesen
influenza
viru
et
al
et
al
newcastl
diseas
viru
gotoh
et
al
respiratori
syncyti
viru
sugru
et
al
extens
research
effort
yield
detail
inform
proteas
inhibitor
review
de
clercq
konvalinka
et
al
midd
et
al
larg
amount
data
also
avail
hcv
foot
et
al
pawlotski
et
al
razon
sarscov
proteas
inhibitor
pillaiyar
et
al
although
yet
inhibitor
latter
target
approv
clinic
use
numer
approv
drug
synthet
peptid
deriv
natur
proteolyt
substrat
target
virus
modifi
improv
vivo
effect
relat
bioavail
stabil
numer
vitro
assay
monitor
activ
proteas
inhibitor
includ
commerci
kit
develop
classic
method
use
synthet
peptid
mimic
target
site
proteas
although
method
describ
origin
design
screen
activ
viral
proteas
presenc
inhibitor
adapt
purpos
simpli
chang
peptid
sequenc
target
site
proteas
interest
cleavag
yield
usual
monitor
either
colorimetr
ding
yang
zhou
et
al
chang
fluoresc
trigger
releas
fluoresc
label
amc
rhodamin
grant
et
al
fluorogen
substrat
use
determin
activ
coronaviru
proteas
screen
inhibitor
kuo
et
al
lee
et
al
park
et
al
song
et
al
tomar
et
al
wang
et
al
yang
et
al
zhao
et
al
recent
describ
arrang
employ
nanoparticl
feltrup
singh
khalilzadeh
et
al
udukala
et
al
wang
et
al
zeng
et
al
quantum
dot
bioconjug
lee
kim
li
et
al
medintz
et
al
immobil
fluoresc
luminesc
label
peptid
substrat
altern
cleavag
product
may
monitor
analysi
proteolyt
product
mass
spectrometr
method
hu
et
al
joshi
et
al
lathia
et
al
et
al
analyt
hplc
teruya
et
al
electrochem
method
base
differ
penetr
substrat
cleavag
product
membran
polyionselect
sensor
gemen
meyerhoff
han
et
al
studi
specif
inhibitor
bind
extend
research
ration
design
inhibitor
xray
nmr
structur
proteas
complex
inhibitor
may
determin
report
numer
case
proteas
review
ghosh
et
al
hcv
yilmaz
et
al
mer
cellbas
assay
provid
addit
inform
includ
capabl
inhibitor
pass
cell
membran
stabil
cytoplasm
gener
determin
infect
plaqu
cytotox
assay
presenc
proteas
inhibitor
may
use
confirm
one
eleg
exampl
exploit
cytotox
hiv
proteas
cell
transfect
proteas
precursor
fuse
gfp
absenc
inhibitor
proteas
autocatalyt
activ
cleav
broad
varieti
cellular
protein
result
activ
apoptosi
cell
death
cummin
badley
rumlova
et
al
toxic
effect
suppress
activ
inhibitor
result
product
gfp
signal
surviv
cell
lindsten
et
al
anoth
eleg
approach
hiv
coxsackieviru
proteas
undergo
autocatalyt
cleavag
employ
construct
proteas
gene
insert
sequenc
encod
dnabind
domain
domain
activ
transcript
report
gene
dasmahapatra
et
al
murray
et
al
proteasemedi
cleavag
separ
dnabind
domain
transactiv
domain
result
failur
report
gene
transcript
approach
also
modifi
gfp
report
gene
hilton
wolkowicz
coexpress
cleavageactiv
luciferas
substrat
merscov
proteas
permit
livecel
imag
quantif
enzym
activ
kilianski
et
al
need
develop
new
antivir
compound
like
persist
long
term
although
enorm
progress
molecular
biolog
method
especi
rna
silenc
bioinformat
imag
structur
biolog
techniqu
virus
present
challeng
target
drug
develop
due
flexibl
adapt
caus
errorpron
copi
genom
result
emerg
drugresist
mutant
viral
integr
host
genom
inhibitor
toxic
obstacl
provid
overview
vitro
method
includ
cellbas
assay
may
suitabl
screen
antivirot
interfer
key
step
viral
life
cycl
target
either
viru
cellencod
protein
requir
infect
